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Abstract
Background: Assessment of the shape and dimensions of PDA is usually done angiographically and in the majority of
cases need arterial access.
Our aim was to evaluate the value of routine 2 D echocardiography (ECHO) in predicting type, dimensions of PDA
and to anticipate device size to be used during the intervention.
Material and methods: The charts of all patients who underwent transcatheter closure of PDA between January 2015 and
December 2020 were reviewed. Their pre-procedure ECHO and catheterization details at the time of device closure were
analyzed.
Results: Total of 139 patients were reviewed and 8 were excluded because of lack of adequate echocardiographic or
angiographic images. The mean age and weight of the study population were 2.6 ± 2.5 years (range 0.2e14 years) and
11.2 ± 7.8 kg (range: 1.5e57 kg), respectively. There was no statistically signiﬁcant difference in PDA narrowest diameter
(p ¼ 0.99) and predicted device type (p ¼ 0.54) between Echo and angiography. Echo slightly overestimated PDA length
(p ¼ 0.01) and aortic ampulla dimension (p ¼ 0.047), while morphology of PDA was correctly identiﬁed in the majority
of cases (82%).
Conclusions: Pre-procedure echocardiography correlates well with angiographically obtained measurements and hence
can be used to estimate PDA diameter, shape and guide device decide selection. Routine echocardiography can be used
successfully to plan the intervention and in some cases to guide transcatheter closure.
Keywords: Patent ductus arteriosus, Echocardiographic guidance, Comparison echocardiography and angiography,
Transcatheter closure

1. Introduction

T

ranscatheter device closure (TCC) of patent
ductus arteriosus (PDA) is currently the treatment of choice for PDA occlusion across all ages [1].
The morphology of PDA is quite variable both with
regard to its shape and dimensions which have
procedural implications for TCC [2]. Accordingly, a

wide variety of devices of different shapes and
sizes have been developed to achieve successful
occlusion of different PDA types. Comprehensive
assessment of the shape and dimensions of the
PDA, including diameter of ductal ampulla, length,
and narrowest PDA diameter at its insertion into the
pulmonary artery, are essential to determine the
feasibility for device closure and select the
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appropriate device type and size without causing
obstruction to ﬂow in the aorta or left pulmonary
artery [2,3]. This is done in the cardiac catheterization laboratory by reviewing the images obtained on
aortic angiography. The PDA is well proﬁled on
aortic angiography but at the cost of exposure to
radiation and occasionally, especially for large PDA,
more than one angiogram is required to correctly
proﬁle the PDA anatomy. However, approximately
two decades ago, Ramaciotti C et al. (2002) showed
that in majority of the cases, PDA dimensions can be
reliably obtained using two dimensional and color
Doppler echocardiography [4].
Recently, transthoracic echocardiography (TTE)
guided device closure of the PDA has been explored
as an attractive option as it avoids radiation exposure
to the patient and the operator, in addition it reduces
contrast administration to the patient. The results of
some case series reporting closure of PDA under TTE
guidance in children and adult patients [5e8] are
encouraging. Recently this has been also noticed in
extremely low birth weight infants [9e11]. Despite
these reports, angiographic delineation of PDA
morphology and its dimensions remains a central
step in most centers to select an appropriate device.
Our aim was to evaluate the value of pre-procedure routine 2 D echocardiography to predict type
and dimensions of PDA and to anticipate device size
to be used during the intervention.

2. Methods and patients
In a retrospective fashion, all patients who underwent attempted device closure of PDA at our
institution from January 2015 to December 2020
constituted the study population. Their TTE prior to
the device closure of PDA was compared with the
aortic angiograms at the time of device closure of
the PDA retrospectively. Details of the devices used
to occlude the PDA were obtained from the procedure note.
2.1. Exclusion criteria
Inadequate echocardiographic or angiographic
images to reliably measure PDA dimensions. Patients with less than 1.5 kg body weight or premature babies. Patients with duct dependent lesions
and PDA with elevated pulmonary vascular
resistance.
2.2. Echocardiography
All echocardiographic studies were performed
using IE33; Philips Medical Systems, (Eindhoven,

Abbreviation
PDA
Patent ductus arteriosus
Echo
2D-echocardiography
TCC
Transcatheter device closure
ADO I and II
Amplatzer Duct Occluder

The Netherlands). The 2D and color Doppler image
loops obtained from the high left parasternal view
(ductal view) were reviewed by a senior pediatric cardiologist blinded to the ﬁndings of the
catheterization procedure. The best frame clearly
delineating the anatomy of the PDA and its connections with both the aorta and the pulmonary artery
was selected. Often it was a combination of 2 D echo
image and color Doppler (Fig. 1a). We classiﬁed the
PDA based on its morphology using a very modiﬁed
Krichenko classiﬁcation “conal, conal small, tiny,
convex (aortic ampulla longer than length of PDA),
window type, tubular, and elongated” [2,3]. The
diameter of the ductal ampulla at the aortic end, its
length and the narrowest PDA diameter at the pulmonary end were measured using electronic calipers
available in the Xcelera Cardiology Information
Management, Philips, The Netherlands (Fig. 1b,c).
2.3. Aortic angiogram
Venous and arterial access were obtained in most
cases. Aortic angiograms were performed as a
power injection using either a pigtail or multipurpose catheter with cameras in straight lateral and
anterior posterior position. If the PDA could not be
clearly delineated, a right anterior oblique view was
performed to visualize it. The angiograms were
reviewed to select the frame best deﬁning the
anatomy of the PDA mostly in the straight lateral
projection. The shape of the PDA and PDA dimensions performed using electronic calipers as
shown in (Fig. 2a,b,c) were recorded. Devices used
to close the PDA were Amplatzer duct occluder I or
II (ADO I, ADO II) and detachable coils of different
diameters.
2.4. Comparison of echocardiographic and
angiographic ﬁndings and choice of device selection
was performed
For each case, the type of PDA established on
echocardiography was compared with that noted on
angiography. Similarly, the PDA dimensions; aortic
diameter, length of the PDA, and narrowest diameter
measured with the two modalities were compared.
An experienced investigator (MOG), blinded to
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Fig. 1. Measurement of PDA dimensions by TTE. (1a) Color compare image in high parasternal view showing PDA. (2a) PDA measurements: (A)
PDA narrowest diameter at pulmonary end (B) Length of the PDA and (C) diameter of the PDA at aortic end. (3a) Actual PDA measurements are
shown.

Fig. 2. Measurement of PDA dimensions by angiography in straight lateral projection. (1a) Image selection for measuring the PDA in lateral view.
(2a) PDA Measurements: (A) PDA narrowest diameter at pulmonary end (B) Length of the PDA and (C) diameter of the PDA at aortic end. (3a)
Actual PDA measurements are shown.
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catheterization data, reviewed the morphology and
dimensions of each PDA on echocardiography and
predicted the type and size of the PDA device suitable to successfully occlude the given PDA. Another
experienced investigator (ZA) reviewed the PDA
morphology and dimensions on angiograms of all
patients and recorded the device choice and size
based on angiographic ﬁndings (Fig. 3a,b).

3.1. PDA narrowest diameter
The narrowest diameter of the PDA measured by
TTE and angiography for the study population was
comparable; 2.53 ± 1.02 mm vs 2.53 ± 1.22 mm;
p ¼ 0.99 (Table 1). BlandeAltman plot analysis
revealed no signiﬁcant bias between TTE and angiography with a standard deviation of 0.9 and narrow
95% limits of agreement of 1.8 and 1.8 (Fig. 4a).

2.5. Statistical analysis
3.2. Aortic ampulla diameter
Descriptive statistics were used to report continuous
variables including means and standard deviations.
The echocardiographic PDA dimensions at the
ampulla, pulmonary end and length were compared
to angiogram dimensions using a two tailed Student's t
test. P value of <0.05 was considered statistically signiﬁcant. In addition, agreement between the two
modalities was evaluated by BlandeAltman plot
analysis using 95% conﬁdence intervals [12]. Qualitative variables between echocardiography and angiography such as the PDA shape and device type were
compared using Chi square test.

3. Results
Total of 139 patients were reviewed and 8 were
excluded because of lack of adequate echocardiographic or angiographic images. The mean age and
weight of the study population were 2.6 ± 2.5 years
(range 0.2e14 years) and 11.2 ± 7.8 kg (range:
1.5e57 kg) respectively. Catheterization procedures
were performed exclusively using transvenous access in 33 (29%) patients. In three patients the device
or coil embolized (2.3%) but was retrieved successfully and the PDA was closed with a larger device.

There was a statistically signiﬁcant difference between the diameter of the aortic ampulla on TTE vs
angiography; 10.2 ± 3.1 mm vs 9.6 ± 2.9 mm, p ¼ 0.047
(Table 1). BlandeAltman plot analysis revealed a
mean bias of 0.57 between TTE and angiography with
a standard deviation of 3.2 and wide 95% limits of
agreement of 7.0 and 5.8 (Fig. 4b).
3.3. PDA length
Echocardiography slightly overestimated the PDA
length compared to angiography and the difference
was statistically signiﬁcant; 10.5 ± 3.1 mm vs
9.7 ± 2.9 mm; p ¼ 0.01 (Table 1). BlandeAltman plot
analysis revealed a bias of 0.85 between TTE and
angiography with a standard deviation of 3.8 and
wide 95% limits of agreement of 8.5 and 6.8
(Fig. 4c).
3.4. PDA type (shape)
The difference between the two imaging modalities in determining the PDA type was statistically

Fig. 3. Comparison of PDA type between Echocardiography and angiography showing in both a conal shape PDA of similar measurements. 3a) Echo:
Smallest diameter (pulmonic end) ¼ 3 mm. Largest diameter (aortic end) ¼ 4.4 mm. Ductal length ¼ 10 mm. 3b) Angiography: Smallest diameter
(pulmonic end) ¼ 2.6. Largest diameter (aortic end) ¼ 3.8. Ductal length ¼ 12 mm.

Table 1. Comparison between PDA measurements and types of PDA by
echocardiography vs angiography.
PDA
Dimensions (mm)

Echocardiography

Angiography

P value

Narrowest
Diameter
Aortic Ampulla
Diameter
PDA Length
PDA Type:
Conal
Conal small
Convex
Tiny
Tubular
AP Window
Elongated

2.53 ± 1.02

2.53 ± 1.22

0.99

10.2 ± 3.1

9.6 ± 2.9

0.04

10.5 ± 3.1

9.7 ± 2.9

0.01

90
17
9
7
8
0
0

107
5
7
5
1
4
2

PDA: Patent Ductus Arteriosus; AP window ¼ aorto pulmonary
window.

signiﬁcant (c2 ¼ 87.9, p < 0.01), in spite of that, the
shape of the PDA was correctly identiﬁed in the
majority of cases [108 patients (82%)].
3.5. Device selection
The type and size of the device (either Amplatzer
or coil) used based on angiography was correctly
predicted by TTE in the majority of cases (n ¼ 115)
and the difference between the two modalities in
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device selection was not statistically signiﬁcant
(c2 ¼ 1.23, p ¼ 0.54).
A subgroup analysis of patients less than one year
of age (n ¼ 40) was performed. In this subgroup
there was no statistically signiﬁcant difference in
any of the measurements of echocardiography vs
angiography respectively: PDA narrowest diameter
2.98 ± 0.93 vs 2.93 ± 1.19; p ¼ 0.7, PDA ampulla
9.55 ± 2.23 vs 9.04 ± 2.92; p ¼ 0.3, PDA length
10.42 ± 2.84 vs 10.04 ± 2.56; p ¼ 0.4, PDA shape
(c2 ¼ 8.9, p ¼ 0.1), device type (c2 ¼ 1.3, p ¼ 0.53)].

4. Discussion
Percutaneous occlusion of the PDA under echocardiography guidance avoiding arterial complications and administration of contrast agent is being
explored by many investigators [5,6]. While positioning of the device and adequacy of PDA occlusion
can be reliably monitored under echocardiographic
guidance [8], one of the challenges is appropriate
device selection without angiographic delineation of
the PDA anatomy. Current experience of closing
PDA under echocardiographic guidance suggests
that this approach can be successful in most cases
but the examiner's ability to select appropriate devices solely based on echocardiographic imaging
has not been systematically investigated.

Fig. 4. Bland Altman Plot Analysis. a) Excellent agreement between echo and cath PDA narrowest diameter. The large-dash line represents the mean
difference which coincides with zero indicating no signiﬁcant bias. Small edashed lines indicate the upper and lower 95% limits of agreement which
is narrow. b) Modest agreement with wide scatter between echo and cath ampulla diameter. c) Weak agreement with wide scatter between echo and
cath PDA length.
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In this retrospective study of 131 patients, we
found that routine echocardiography performeddespite its limitations-extremely well in determining
the PDA's narrowest diameter and in predicting the
appropriate occluding device type. On the other
hand, echocardiographic measurements of the ampulla's diameter and PDA length were overestimated when compared to angiography.
However, this difference was not clinically relevant.
Furthermore, echocardiography was unable to
accurately describe the PDA shape in some patients.
In children under one year of age there was excellent correlation between Echo and angiographic
ﬁndings in all the measurements. This is likely due
to better acoustic windows in infants.
Despite these ﬁndings, the type and size of the
device to successfully occlude the PDA could be
correctly predicted by transthoracic echocardiographic imaging of the PDA in the parasternal long
axis plane using the ductal view. This is an interesting and important observation. The most relevant
aspect of the procedure is successful occlusion of the
PDA without causing obstruction to ﬂow in the aorta
and pulmonary artery. In this regard, echocardiography seems to perform as well as angiography. In
our series the majority (117/131 - 89%) of PDAs were
either conal or convex shape-more than previously
described by Kritchenko et al. (1989). Occlusion was
achieved using either Amplatzer duct occluders
(ADO I or ADO II) device or detachable coils for
smaller PDAs. In our practice the ADO device selection on angiography is made based on the narrowest diameter, diameter of the aortic ampulla and
length of the PDA. In long ductus (>7 mm), we
incorporate the mid-PDA diameter in decision
making for device selection.
The shapes of the conal and convex type PDA are
slightly different but, in our experience, the ADO I is
well suited for both shapes. In contrast, the geometry of tubular, AP window type, and tiny PDAs are
less common (Table 1). Analysis of the data after
excluding those cases did not change the results
except that the diameter of the aortic ampulla
measured by echocardiography were similar to
angiographic measurements (10.3 ± 3.1 mm vs
9.9 ± 2.8 mm, p ¼ 0.1 respectively). The results of the
narrowest diameter, PDA length, shape, and device
selection remained unchanged. This is likely
because the number of tubular and AP window type
PDAs were very small and tiny PDAs can be
occluded easily with a detachable coil or small
ADOI/ADO II device, depending upon the size of
the aortic ampulla and on the preference of the
operator.

We often use detachable coils for PDA with the
narrowest diameter less than 1.5 mm. A coil with
2e3 times the narrowest diameter of the PDA and
with enough loops to ﬁll the ductal ampulla achieve
successful occlusion in these cases. However, in our
experience, TTE guidance alone could be very
challenging in these cases as the operator is unable
to visualize the whole coil cable. Therefore, in case
the operator needed to use detachable coil echocardiography alone might not be the best option and
we ﬁnd limited ﬂuoroscopy quite beneﬁcial in this
situation. Fluoroscopy might also be used to expedite some aspects of the TTE guided anterograde
PDA occlusion (8).
Therefore, TTE appears to be a suitable imaging
modality on its own to select an appropriate PDA
occluding device for conal, convex, and likely tiny
PDAs but this observation cannot be generalized for
less common types of PDA, such as large tubular or
AP window type PDA [3]. Rarely, PDAs demonstrate an expansile phenomenon, where the size of
the PDA, including the narrowest diameter changes
dramatically from small to large [13]. We have also
come across a case where a PDA with a small narrowest diameter on initial angiography expanded to
a huge PDA after catheter manipulation. In such
cases, prior echocardiographic assessment and device selection would obviously not remain relevant.
Fortunately, these are rare situations, but the operator and the family need to be aware of such a
possibility, especially when the access to devices is
limited.

5. Access for PDA closure
Since the inception of percutaneous device
closure of the PDA, femoral arterial access to
perform aortic angiography and delineate the PDA
anatomy has been the ﬁrst essential step and remains so in many catheterization laboratories.
However, arterial access could be associated with
signiﬁcant complications, including arterial thrombosis and complete or partial occlusion of the
femoral artery in approximately 0.8%e7% of children and as high as 19% in young infants weighing
less than 4 Kg [14,15]. Rarely limb threatening
ischemia is encountered, necessitating thrombolysis
or surgical intervention [16].
Transvenous PDA occlusion under TTE guidance
without arterial access has been shown to be
feasible. It offers an obvious advantage over conventional approach by avoiding arterial access and
associated arterial complication and has allowed
bedside occlusion of PDA in fragile premature

newborns without transferring them to the catheterization laboratory [11]. Despite these advantages
TTE guided transvenous approach without arterial
access is still not widely practiced, as excellent
angiographic imaging of the PDA can be sometimes
challenging. The ﬁndings of our study lend further
support for wider acceptance of this approach.

6. PDA closure in developing countries
Our ﬁndings have another important practical
implication for a large patient population and pediatric cardiologists in underdeveloped countries. In
these resource limited populations, the operator
does not have unrestricted access to a variety of
devices in all sizes. Feasibility of echocardiography to
reliably narrow down and predict the type and size
of the device is a welcoming tool to guide planning a
procedure with successful outcome in advance.
Occasionally PDA cannot be accessed anterograde
and in these cases, retrograde occlusion can also be
performed solely under TTE guidance using ADO
II, vascular plugs or detachable coils. ADO I is not
suitable for retrograde occlusion of PDA.
6.1. Limitations
In addition to the usual limitations of the retrospective single center study and selection bias, the
ﬁndings of this study are primarily applicable to
young children with conal and convex shape PDA.
These ﬁndings cannot be generalized to other less
common types or unusually large PDAs (>7 mm).
As expected, the conal type represents the majority
of the patients studied. Hence the correlation between echo and angio ﬁnding was high. This might
not be the case with the less common PDA types.
Because of low numbers of the other PDA types,
predictive value analysis was not performed.
6.2. Conclusion
In young children echocardiographic imaging of
the PDA in the parasternal long axis plane using
ductal view allows reliable assessment of the narrowest diameter of the PDA similar to angiography.
However, this imaging technique is less accurate in
measuring the aortic ampulla and the length of the
PDA in children older than one year of age. Despite
these limitations, appropriate selection of ADO devices or detachable coils can be made based on the
shape and narrowest diameter of conal/convex
shape PDAs. With advancement in technology and
better ECHO resolution it is possible that in future
straight forward PDA device occlusion in younger
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population can solely be done under ECHO guidance. At this stage, more prospective data is needed
before adopting echo as a sole method to guide PDA
device closure.
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